Published on 10.03.2023
The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) is offering a position as doctoral researcher in the field of biological screening (f/m/d) for the Helmholtz Imaging Project: Automated image-based detection of early toxicity events in zebrafish larvae (ImageTox).
HIPS focusses on identifying and developing new treatment options for infectious diseases with an emphasis on natural product research. Especially researchers in the department of Microbial Natural Products are aiming to identify, investigate and optimize novel natural product based actives, applying diverse approaches and methods mainly from the field of biotechnology, microbiology, molecular biology and biochemistry.
The department Microbial Natural Products entertains a zebrafish facility since 2017, and zebrafish larvae models (not classified as animal experiments according to EU Directive 2010/63/EU) are applied to characterize new natural product-based antibiotics. One research focus is to establish a detailed understanding of potential toxicological properties and off-target effects of these new antibiotics. You will be responsible to establish, improve and modify toxicity models in zebrafish larvae (e.g. based on OECD guideline 236) with the aim to make them available for medium-throughput microscopy-based screening.
In the course of a project funded by Helmholtz Imaging, you will work closely together with scientists from HIPS and the CISPA Helmholtz Center for Information Security with the goal to provide a high-quality workflow for the acquisition and automated image-based analysis of early toxicological events. You will apply the established screens to assess in particular advanced natural product classes currently under development as novel therapeutic agents. Such studies will be followed by a more detailed assessment of underlying modes and mechanisms of toxic action applying state-of-the-art technology to characterize e.g., direct off-target binding, enzyme activity and transporter functionality. The aim will be the early identification of promising antibiotic drug candidates through de-risking of new compound classes with regard to potential adverse (side) effects.
Disabled persons are given preference in the case of equal professional qualification. The HIPS aims for professional equality between women and men. The position is suitable for part-time work.
Starting date: May 1 st, 2023 – initial contract for 3 years
Salary: E13 TVöD/Bund (55%)
Probation period: 6 months
Working place: Saarbrücken
Published: February 28th, 2023
Closing date: April 11th, 2023
For more details regarding the position, please contact Dr. Jonas Baumann at